verapamil hydrochloride
Generic: verapamil hydrochloride
Labeler: teva pharmaceuticals incDrug Facts
Product Profile
Brand Name
verapamil hydrochloride
Generic Name
verapamil hydrochloride
Labeler
teva pharmaceuticals inc
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Routes
Active Ingredients
verapamil hydrochloride 360 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0591-2886
Product ID
0591-2886_319554df-fc0d-428a-9799-a352100f1ce9
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA019614
Marketing Start
1990-05-29
Marketing End
2026-08-31
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
05912886
Hyphenated Format
0591-2886
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
verapamil hydrochloride (source: ndc)
Generic Name
verapamil hydrochloride (source: ndc)
Application Number
NDA019614 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 360 mg/1
Packaging
- 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (0591-2886-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "319554df-fc0d-428a-9799-a352100f1ce9", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897624"], "spl_set_id": ["0742cf97-601b-4c13-a6c3-1a6a616ed292"], "manufacturer_name": ["Teva Pharmaceuticals Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (0591-2886-01)", "package_ndc": "0591-2886-01", "marketing_end_date": "20260831", "marketing_start_date": "19900529"}], "brand_name": "Verapamil Hydrochloride", "product_id": "0591-2886_319554df-fc0d-428a-9799-a352100f1ce9", "dosage_form": "CAPSULE, DELAYED RELEASE PELLETS", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "0591-2886", "generic_name": "verapamil hydrochloride", "labeler_name": "Teva Pharmaceuticals Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "360 mg/1"}], "application_number": "NDA019614", "marketing_category": "NDA", "marketing_end_date": "20260831", "marketing_start_date": "19900529"}